Latest AI and machine learning research in urology for healthcare professionals.
The increasing demand for point-of-care detection of low-concentration cancer biomarkers has necessitated the development of innovative nanozyme-based sensing technologies. Here, a smartphone-integrated platform is presented that utilizes artificial intelligence (AI) to detect abnormal levels of the prostate cancer marker sarcosine (Sar) in humans. The platform comprises a histidine (His)-modified...
PURPOSE OF REVIEW: Renal cell carcinoma (RCC) is a prevalent and increasingly diagnosed malignancy associated with high mortality and recurrence rates. Traditional diagnostic and therapeutic approaches have limitations due to the disease's molecular heterogeneity. This review aims to explore how the integration of omics sciences-genomics, transcriptomics, proteomics, and metabolomics-can enhance t...
PURPOSE: A critical limitation to deployment and utilization of Artificial Intelligence (AI) algorithms in radiology practice is the actual integratio...
The rapid advancements in artificial intelligence (AI) carry the promise to reshape abdominal imaging by offering transformative solutions to challeng...
OBJECTIVES: This study aimed to predict and classify MRI PI-RADs scores using different machine learning algorithms and to detect the concordance of P...
OBJECTIVES: Since coronary artery disease (CAD) is a common comorbidity in patients with aortic valve stenosis, invasive coronary angiography (ICA) ca...
Prostate cancer (PCa) remains a leading cause of cancer-related morbidity and mortality among men worldwide. Multiparametric MRI (mpMRI) is currently ...
: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer, and its prognosis is closely linked to the International Society...
: Magnetic resonance imaging (MRI) is crucial in detecting suspicious lesions and diagnosing clinically significant prostate cancer (csPCa). However, ...
Cardiogenic shock (CS) is a life-threatening complication of ST-elevation myocardial infarction (STEMI) and remains the leading cause of in-hospital ...
Clear cell renal carcinoma (ccRCC) is the most prevalent and aggressive subtype of kidney cancer. Targeting ccRCC metabolism is a promising therapeuti...
Prostate cancer (PCa) is a leading cause of cancer-related mortality in men, with Gleason grading critical for prognosis and treatment decisions. Mach...
The association between obesity and cancer risk carries substantial public health ramifications as obesity promotes cancer advancement via many cellul...
While white matter myelin primarily functions to accelerate conduction velocity and has been extensively studied in schizophrenia-spectrum disorders (...
The combination therapy of mirabegron (MIR) and tadalafil (TAD) has gained significant attention in clinical practice for the treatment of Benign Pros...
RATIONALE AND OBJECTIVES: End-stage renal disease is characterized by an irreversible decline in kidney function. Despite a risk of chronic dysfunctio...
Over the past few decades, the rising burden of metabolic disease, including type 2 diabetes, prediabetes, obesity, and metabolic dysfunction-associat...
BACKGROUND: Digitalization in urology is bringing about profound changes. While artificial intelligence (AI)-supported diagnoses, telemedical consulta...
BACKGROUND AND PURPOSE: Synthetic CT (sCT) generation from cone-beam CT (CBCT) must maintain stable performance and allow for accurate dose calculatio...
BACKGROUND: It is widely acknowledged that dietary habits play a pivotal role in maintaining optimal intestinal health. Fecal incontinence (FI) is a d...